Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

Chicago hospital offers $200 CT calcium scans

The imaging department at Saints Mary and Elizabeth Medical Center, a member of Resurrection Health Care in Chicago, is offering a coronary calcium CT scan for the discounted fee of $199 during October and November of this year.

FDA approves Covidien generic Cardiolite

The FDA has approved Covidiens abbreviated new drug application (ANDA) for its preparation kit for Technetium Tc 99m sestamibi injection, a myocardial perfusion-imaging (MPI) agent used for detecting coronary artery disease.

Lantheus joins Bracco for promotion of CardioGen-82

Lantheus Medical Imaging has entered an agreement to co-promote Braccos CardioGen-82, a myocardial perfusion PET imaging agent.

Multi-center study confirms efficacy of high-speed SPECT camera

The D-SPECT high-speed SPECT camera was proven, in a single-center study, to be equal to conventional SPECT regarding its quantification of myocardial perfusion, albeit at seven-times the speed. Now, researchers from four centers testing the new technology confirm the earlier findings in a study presented at the American Society of Nuclear Cardiology (ASNC) conference.

Following Appropriateness Criteria can reduce unnecessary cardiac testing

BOSTON—Hospitals that perform cardiac nuclear stress testing under the2007 Appropriateness Criteria from the American Society of NuclearCardiology (ASNC) and American College of Cardiology (ACC) could reduceunnecessary testing and potentially reduce costs, according to a studypresented Sept. 12 at the ASNC conference.

Expert: Myocardial perfusion SPECT may no longer be best noninvasive test for heart disease

BOSTON—While the era for cardiac SPECT imaging continues to beexciting, the nuclear cardiology community needs to address thechallenges of increased throughput efficiency, lower cost delivery andreduced dosimetry to remain competitive and cutting edge, according toan analysis presented Sept. 12 by Timothy M. Bateman, MD, at theAmerican Society of Nuclear Cardiology (ASNC) conference.

Beta blockers, channel blockers are safe to use in outpatient CTA settings

BOSTON—Medications like beta blockers (BB) and calcium channel blockerscan be safely used in an outpatient setting and significantly reducethe intravenous (IV) BB to slow heart rate on the day of CT angiography(CTA), according to a poster presentation at the American Society ofNuclear Cardiology (ASNC) conference on Sept. 12.

GE licenses Syntermed diagnostic tool for heart failure

BOSTON—GE Healthcare has licensed Syntermed's SyncTool, a newdiagnostic tool for heart failure, and demonstrated the tool on its GEXeleris 2 workstations at the American Society of Nuclear Cardiology(ASNC), Sept. 10-14.

Displaying 2513 - 2520 of 2637

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.